We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Figure 2

Figure 2. From: Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective.

Disease-specific survival rates of low-, intermediate- and high-risk groups treated with primary androgen deprivation therapy (cited from Ref. 13).

Mikio Namiki, et al. Asian J Androl. 2012 May;14(3):451-457.
2.
Figure 1

Figure 1. From: Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective.

Comparison of the efficacy of hormonal therapy between Japanese American and Caucasians living in Hawaii (modified from Ref. 7).

Mikio Namiki, et al. Asian J Androl. 2012 May;14(3):451-457.
3.
Figure 3

Figure 3. From: Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective.

Treatment algorithm for patients with low- and intermediate-risk localized prostate cancer (cited from Ref. 13). PADT, primary androgen deprivation therapy; PSA, prostate-specific antigen. Group G: good response group; Group P: poor response group.

Mikio Namiki, et al. Asian J Androl. 2012 May;14(3):451-457.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk